Venturi Wealth Management LLC Has $2.07 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Venturi Wealth Management LLC increased its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 427.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 22,728 shares of the company's stock after purchasing an additional 18,423 shares during the period. Venturi Wealth Management LLC's holdings in Colgate-Palmolive were worth $2,066,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. FMR LLC boosted its holdings in shares of Colgate-Palmolive by 65.6% in the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company's stock valued at $700,642,000 after purchasing an additional 2,674,807 shares in the last quarter. Barclays PLC lifted its position in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after buying an additional 2,132,747 shares during the last quarter. State Street Corp boosted its stake in Colgate-Palmolive by 3.8% in the third quarter. State Street Corp now owns 48,436,276 shares of the company's stock valued at $5,028,170,000 after buying an additional 1,784,411 shares in the last quarter. Nordea Investment Management AB grew its position in Colgate-Palmolive by 32.5% in the fourth quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company's stock valued at $462,121,000 after acquiring an additional 1,247,731 shares during the last quarter. Finally, AustralianSuper Pty Ltd grew its position in Colgate-Palmolive by 941.9% in the fourth quarter. AustralianSuper Pty Ltd now owns 1,138,655 shares of the company's stock valued at $103,515,000 after acquiring an additional 1,029,364 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of research analyst reports. Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a research note on Monday, February 3rd. Morgan Stanley cut their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. TD Cowen lowered their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday, January 8th. Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a report on Friday, January 17th. Finally, Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $101.16.

Colgate-Palmolive Trading Up 1.9 %

Shares of NYSE CL traded up $1.69 during midday trading on Friday, reaching $89.56. The stock had a trading volume of 4,747,229 shares, compared to its average volume of 4,884,892. The company's 50 day moving average price is $88.94 and its 200 day moving average price is $95.91. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. Colgate-Palmolive has a twelve month low of $84.45 and a twelve month high of $109.30. The firm has a market cap of $72.68 billion, a price-to-earnings ratio of 25.44, a price-to-earnings-growth ratio of 4.18 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the firm earned $0.87 earnings per share. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.23%. Colgate-Palmolive's payout ratio is 56.82%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.